COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,846 Articles (22,553 medRxiv, 8,293 bioRxiv)

Most recent first Previous |  Page 2046: Articles 20451-20460  | Next

COVID-19 Wastewater Epidemiology: A Model to Estimate Infected Populations
McMahan, C. S., Self, S., Rennert, L., Kalbaugh, C., Kriebel, D., Graves, D., Deaver, J. A., Popat, S., Karanfil, T., Freedman, D. L.
10.1101/2020.11.05.20226738 — Posted: 2020-11-07
Interventions targeting nonsymptomatic cases can be important to prevent local outbreaks: COVID-19 as a case-study
Lovell-Read, F. A., Funk, S., Obolski, U., Donnelly, C. A., Thompson, R. N.
10.1101/2020.11.06.20226969 — Posted: 2020-11-07
Validation of home oxygen saturations as a marker of clinical deterioration in patients with suspected COVID-19
Inada-Kim, M., Chmiel, F. P., Boniface, M. J., Pocock, H., Black, J. J. M., Deakin, C. D.
10.1101/2020.11.06.20225938 — Posted: 2020-11-07
Longitudinal Physiological Data from a Wearable Device Identifies SARS-CoV-2 Infection and Symptoms and Predicts COVID-19 Diagnosis
Hirten, R. P., Danieletto, M., Tomalin, L., Choi, K. H., Zweig, M., Golden, E., Kaur, S., Helmus, D., Biello, A., Pyzik, R., Nabeel, I., Charney, A., Glicksberg, B. S., Levin, M., Reich, D., Charney, D., Bottinger, E. P., Keefer, L., Suarez-Farinas, M., Nadkarni, G. N., Fayad, Z. A.
10.1101/2020.11.06.20226803 — Posted: 2020-11-07 Discussion: Onsite
Kinetics of viral load, immunological mediators and characterization 1 of a SARS-CoV-2 isolate in mild COVID-19 patients during acute phase of infection
Anantharaj, A., Gujjar, S., Kumar, S., Jain, N., Wangchuk, J., Khan, N. A., Panwar, A., Kanakan, A., A, V., Vasudevan, J. S., Das, A., Pandey, A. K., Pandey, R., Medigeshi, G. R.
10.1101/2020.11.05.20226621 — Posted: 2020-11-07
Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of New York City Metro Blood Donors using Multiple SARS-CoV-2 Serological Assays: Implications for Controlling the Epidemic and Reopening.
Jin, D. K., Nesbitt, D. J., Yang, J., Chen, H., Horowitz, J., Jones, M., Vandergaast, R., Carey, T., Reiter, S., Russell, S. J., Kyratsous, C., Hooper, A., Hamilton, J., Ferreira, M., Deng, S., Straus, D., Baras, A., Hillyer, C. D., Luchsinger, L. L.
10.1101/2020.11.06.20220087 — Posted: 2020-11-07
Predicting the impact of disruptions in lymphatic filariasis elimination programmes due to the outbreak of coronavirus disease (COVID-19) and possible mitigation strategies
Prada, J. M., Stolk, W. A., Davis, E. L., Touloupou, P., Sharma, S., Munoz, J., Caja Rivera, R. M., Reimer, L. J., Michael, E., de Vlas, S. J., Hollingsworth, D.
10.1101/2020.11.06.20227017 — Posted: 2020-11-07
Alzheimer's and Parkinson's diseases predict different COVID-19 outcomes, a UK Biobank study
Yu, Y., Travaglio, M., Popovic, R., Leal, N. S., Martins, L. M.
10.1101/2020.11.05.20226605 — Posted: 2020-11-07
Medical Capacity Shortages Facilitated the Rapid Dissemination of COVID-19 in Wuhan, New York State, and Italy
Xu, Y., Zhang, C., Qian, L.
10.1101/2020.11.05.20226530 — Posted: 2020-11-07
Synchronization in Epidemic Growth and the Impossibility of Selective Containment
Budich, J. C., Bergholtz, E. J.
10.1101/2020.11.06.20226894 — Posted: 2020-11-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).